Cart
sales@molnova.com
Methazolamide
CAS No. 554-57-4
Methazolamide( Methazolamide | Neptazane | Methenamide | Neptazaneat | Naptazane | N Methylacetazolamide )
Catalog No. M15015 CAS No. 554-57-4
Methazolamide is a carbonic anhydrase inhibitor used to treat glaucoma.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 43 | In Stock |
|
| 200MG | 55 | In Stock |
|
| 500MG | 67 | In Stock |
|
| 1G | 86 | In Stock |
|
Biological Information
-
Product NameMethazolamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethazolamide is a carbonic anhydrase inhibitor used to treat glaucoma.
-
DescriptionMethazolamide is a carbonic anhydrase inhibitor used to treat glaucoma. Target: Carbonic Anhydrase Methazolamide is a carbonic anhydrase inhibitor with Ki of 50 nM, 14 nM and 36 nM for hCA I, hCA II and bCA IV isoforms, respectively.
-
In Vitro——
-
In Vivo——
-
SynonymsMethazolamide | Neptazane | Methenamide | Neptazaneat | Naptazane | N Methylacetazolamide
-
PathwayMembrane Transporter/Ion Channel
-
TargetCarbonic Anhydrase
-
RecptorbCAIV| hCAI| hCAII
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number554-57-4
-
Formula Weight236.27
-
Molecular FormulaC5H8N4O3S2
-
Purity>98% (HPLC)
-
SolubilityEthanol: 3 mg/mL (12.69 mM); DMSO: 47 mg/mL (198.92 mM)
-
SMILESCC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C
-
Chemical NameN-(3-methyl-5-sulfamoyl-1,3,4-thiadiazol-2-ylidene)acetamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Casini A, et al. Bioorg Med Chem Lett, 2003, 13(5), 841-845.
molnova catalog
related products
-
Benzthiazide
Benzthiazide is used to treat hypertension and edema. Like other thiazides, benzthiazide promotes water loss from the body (diuretics).
-
Dorzolamide hydrochl...
Dorzolamide Hcl(L671152 Hcl; MK507 Hcl) is an anti-glaucoma agent, which is a carbonic anhydrase inhibitor.
-
Enpp/Carbonic anhydr...
Enpp/Carbonic anhydrase-IN-1 (compound 1e) is a potent inhibitor of Enpp and carbonic anhydrase, exhibiting IC50s of 1.36, 1.35, 3.00, 0.88, and 1.02 μM for NPP1, NPP2, NPP3, CA-II, and CA-IX respectively.
